<DOC>
	<DOCNO>NCT02286206</DOCNO>
	<brief_summary>The objective 15-day study : 1 . To compare steady-state trough plasma concentration clozapine metabolite norclozapine give daily twice daily ( total daily dose ) 2 . To determine frequency clozapine administration effect : 1 . Symptoms schizophrenia 2 . Adverse effect clozapine 3 . Fasting blood glucose , lipid , creatinine , urea 4 . Weight waist circumference</brief_summary>
	<brief_title>Study Effect Dosing Clozapine Levels</brief_title>
	<detailed_description>It important clinician everything possible optimize use clozapine individual treatment-resistant schizophrenia . To knowledge , publish study evaluate whether twice daily administration clozapine well daily administration term effectiveness tolerability . Although may seem trivial first , consider clozapine relatively short half-life dissociates quickly dopamine D2 receptor , justifies consideration . It take even significance know establish threshold clozapine plasma concentration therapeutic response ( i.e. , 350-420 ng/ml ) determine use steady-state trough plasma sample ( i.e. , approximately 12 hour even dose ) patient administer clozapine twice rather daily .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Participants must age 19 65 Participants must fluent English Participants must psychiatric diagnosis currently treat clozapine daily even Participants must stable dose clozapine least one week ensure steadystate achieve Participants hypersensitive clozapine Participants pregnant lactate Participants childbearing age use reliable contraception Participants postsurgical complication gastrointestinal tract might impair absorption Participants clinically relevant abnormality laboratory parameter Participants potent CYP1A2 metabolic inducer ( e.g. , carbamazepine ; rifampin ) inhibitor ( e.g. , amiodarone ; cimetidine ; efavirenz ; fluoroquinolone antibiotic ; ticlopidine ) add and/or remove medication regimen past two week</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Clozapine</keyword>
	<keyword>Psychotropic Drugs</keyword>
	<keyword>Antipsychotic Agents</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Adverse Effects</keyword>
	<keyword>Drug Monitoring</keyword>
</DOC>